良性前列腺增生症药物消融治疗的研究进展
被引量:1
摘要
良性前列腺增生的发病率越来越高。前列腺内药物消融治疗前列腺增生有望成为一种微创的治疗方法,并已进行了一些研究。本文综述了目前国外关于良性前列腺增生药物消融研究进展。
出处
《国际泌尿系统杂志》
2006年第2期149-151,共3页
International Journal of Urology and Nephrology
参考文献24
-
1Plante MK, Bunnell ML, Trotter SJ, et al. Transurethral prostatic tissue ablation via a single needle delivery system: initial experience with RF energy and ethanol. Prostate Cancer Prostatic Dis, 2002,5(3) :183-188.
-
2Zvara P, Karpman E, Stoppacher R, et al. Ablation of canine prostate using transurethral intraprostatic absolute ethanol injection. Urology,1999,54:411 - 415.
-
3Levy DA, Cromeens DM, Evans R, et al : Transrectal ultrasound-guided intraprostatlc injection of absolute ethanol with and without carmustine: a feasibility study in the caninemodel. Urology, 1999,53:1245 - 1251.
-
4Goya N, Ishikawa N, lto F, et al. Ethanol injection therapy of the prostate forbenign prostatic hyperplasia: preliminary report on application of a new teehnique. J Urol,1999,162:383 - 386.
-
5Chiang PH, Chuang, YC, Huang C , et al. Pilot study of transpefineal injection of dehydrated ethanol in the treatment of prostatic obstruction. UROLOGY, 2003,61:797 - 801.
-
6Plante MK, Bunnell ML, Trotter Sj, et al. Transurethral prostatic tissue ablation via a single needle delivery system: initial experience with radio- frequency energy and ethanol. Prostate Cancer and Prostatic Diseases,2002,5 : 183 - 188.
-
7Plante MK, Gross AL, Kliment J, et al.. Intraprostatic ethanol chemoablation via transurethral and transpefineal injection, BJU Int,2003,91:94-98,
-
8Plante MK , Gross A, Folsom JB et al. Diffusion properties of transurothral intraprostatic injection. BJU international,2004,94,1384 -1388.
-
9Savoca G, De Stefani S, Gattuccio I, et al. Percutaneous ethanol injection of the prostate as minimally invasive treatment for benign prostatic hyperplasia. Eur Urol,2001,40 : 504 - 508.
-
10Ditrolio J, Patel P, Watson RA, et al. Chemo- ablation of the prostate with dehydrated alcohol for the treatment of prostatic obstruction.J Urol, 2002,167:2100 - 2104.
同被引文献10
-
1孙颖浩.α1受体阻滞剂治疗良性前列腺增生研究进展[J].中华男科学杂志,2004,10(7):483-485. 被引量:24
-
2苏南湘,祖雄兵.泽桂癃爽联合哈乐治疗慢性非细菌性前列腺炎的临床研究[J].中国现代医学杂志,2004,14(20):112-113. 被引量:4
-
3姜卫东,张青汉,叶绪龙,董能本.泽桂癃爽对前列腺增生症最大尿流率的影响[J].时珍国医国药,2005,16(5):406-406. 被引量:2
-
4任宇,李宁宁,叶璐,李懿,宋豪,初铮铮,熊鹰.坦索罗辛和特拉唑嗪治疗BPH的系统评价[J].临床泌尿外科杂志,2006,21(9):692-697. 被引量:3
-
5崔露阳.良性前列腺增生治疗药物市场扫描[J].世界临床药物,2007,28(1):58-61. 被引量:2
-
6Nomiya M, Yamaguchi O. A quantitative analysis of mRNA expression of alpha 1 and beta adrenoceptor subtypes and their functional roles in human normal and obstructed bladders [J]. J Urol, 2003, 170 (2Pt1): 649-653.
-
7俞斌,王忠.良性前列腺增生微创治疗进展[J].中华男科学杂志,2007,13(8):739-743. 被引量:18
-
8郭钻,陈卫明.3种中成药治疗良性前列腺增生症成本-效果分析[J].海峡药学,2008,20(8):141-142. 被引量:1
-
9葛京平,龚隽,马宏青,魏武,商学军,张征宇,许松,王东,高建平.萘哌地尔治疗良性前列腺增生伴膀胱过度活动症的临床观察[J].中华男科学杂志,2008,14(10):927-930. 被引量:21
-
10戴岳,祁公任,林已茏,皮子凤,杜飞飞.泽桂癃爽胶囊对大鼠前列腺炎的抑制作用[J].中成药,2001,23(12):896-899. 被引量:16
二级引证文献3
-
1王传伟,陈路佳,张波,赵艳,刘姝,张燕.泽桂癃爽胶囊治疗良性前列腺增生的系统评价[J].中国药业,2015,24(4):16-19. 被引量:7
-
2王建平,李仁坡.泽桂癃爽胶囊治疗膀胱瘀阻型前列腺增生的临床观察[J].中国社区医师,2015,31(13):78-78. 被引量:3
-
3马嘉,邢建月,张宇鹏,刘光珍.中成药治疗良性前列腺增生有效性和安全性的贝叶斯网状Meta分析[J].药物流行病学杂志,2024,33(3):301-318.
-
1王蓉华,李艳娜,王辉.治疗良性前列腺增生药物——爱普列特[J].中国药房,2007,18(34):2701-2703. 被引量:2
-
2郭洁群.治疗良性前列腺增生药物新进展[J].青海医药杂志,1998,28(3):63-64.
-
3杨勇.良性前列腺增生症药物治疗一例[J].中华老年医学杂志,2007,26(7):544-545.
-
4董明明,段雅卿,任吉民.治疗良性前列腺增生药物进展综述[J].中国制药信息,2008,24(11):6-8.
-
5归成,徐红冰.近3年上海市47家医院治疗前列腺增生症药物的应用分析[J].中国药房,2002,13(11):667-668. 被引量:6
-
6杜丰.良性前列腺增生药物临床应用进展[J].中国医刊,2008,43(3):69-72. 被引量:14
-
7王永,白彦满都拉,吉日嘎拉,宣丽颖.治疗良性前列腺增生药物的研究进展[J].内蒙古民族大学学报(自然科学版),2014,29(3):353-355. 被引量:3
-
8归成,徐红冰.近3年上海市47家医院治疗前列腺增生症药物的应用分析[J].中国医院用药评价与分析,2002,2(5):268-269.
-
9高海峰.门诊治疗良性前列腺增生药物的处方分析[J].中华临床医师杂志(电子版),2016,10(11):214-214.
-
10戴新民,王超君,骆海莺,李薇,陈博.军队离退休干部良性前列腺增生用药分析[J].临床合理用药杂志,2010,3(1):16-17.